Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
...land spreading out so far and wide...
'I always root for the underant.'
Have to agree, WING. Not comfortable with the history, not interested in hysteria.
Grazie mille, Signore.
Shock me.
I heard that too, on the same day that someone else said that the new CEO is actually Bigfoot & Ace Frehley will be the next president. I'm dismayed.
Thx a lot BREZ. Yes, I'm confident Big Pharm has been on top of everything for a long time, making moves now. Could be anything, mult lic agreements, who knows? Have to, they know it, & they dont play.
Since it's Big Pharm, it's gonna be the $$$$$ option - that's their league, we're all painfully aware of the global situation.
Appreciate yr words.
TUVM TIMING101. One thought about the Big Pharm consideration: one way or another, GUARANTEED, probably in short order. Personally, I wouldn't be surprised if someone's already quietly jumped all over it.
Here's a bit; don't recall the details...
https://wyobiz.wyo.gov/Business/FilingDetails.aspx?eFNum=065001032194051086137151007051237098006244178238
Changed the logo; it was a generic used by another company's site as well: https://www.gtbiopharma.com/
FOR INFO PURPOSES ONLY - NOT PROMOTING OR KNOCKING ANOTHER COMPANY - DON'T GIVE A DAMN
Respectfully 2nd that. Good words, CPM.
Oh yeah, TUVM, U.B. Incredible.
Yup, Joseph Cotropia cited as 1 of 12 authors.
Yeah, GF kickin' it up today. FUHGETABOUTIT. Got a slice?
Sure, & all aspirins are alike!
'I much fear trouble with the fuselage, Frederic'
Powerful summary.
I think I'm feeling all warm & fuzzy!
Or dung beetles.
I think so. Good mgt histories, products on the market, more in development, business agreements for expansion & distribution, efforts to expand internationally w mgt w applicable regional experience, AND the damn MMs preying. Yup, definitely a sleazy otc P&D. They've probably just stuck a cheap sign on the outer wall of an abandoned strip joint & took a selfie to post. I just know it! SCAM! SCAM! SCAM! Oh no! Beep.
Concur, volume says it all.
Strong management backgrounds as well. Perhaps the MMs smell blood, screwing around w shares & PPS.
Yeah, me too
Get outta town! I know Brennan's & the history of their Foster. Would love to try it; missed Brennan's when I passed thru Nawlins in the late '90s for a meeting. Got to be a guest at Emeril's - trouble walkin after that dinner. Was working in I.T. at Yale-New Haven Hosp.
In that case, may I respectfully suggest the Bananas Flambé?
Got me. Perhaps an industry protocol for safety & assurance in redundancy. If I was directly involved with anything of this nature, I'd quadruple-check everything & be damn certain.
Thx BIRD
TUVM AIRMIKEYY, found it. Check it out (brief, end of 2nd paragraph)...
https://www.yahoo.com/lifestyle/enzolytics-inc-announces-execution-letter-130000549.html
Would someone please refresh my memory about the UC Davis trials? Is that the primate lab?
Agree completely, but check this post:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=159099068
Ties in w this part of the DD:
ITV1, Enzolytics's flagship product, has proven to work extremely effectively in clinical trials abroad to treat HIV. "Enzolytics currently holds a 49% interest in Immunotech Laboratories BG-Europe (Bulgaria). Immunotech BG-Europe has a license for the development and commercialization of Enzolytics Patented ITV-1 Technology." ITV-1 is being marketed in Europe under trade name ImmuH. "The medicine has a positive effect on the treatment of different kinds of cancer, as it stimulates the immune answer and strengthens the immune system..."
https://www.immunotechlaboratoriesbg.com/
https://enzolytics.com/immunh-bg%2Feurope
Although, in re-reading your post, you have a big point in that we're talking about a new product - a powerful product that's a drug, not a supplement. It can be rushed through FDA approval: urgency, "proprietary" industry procedures, who you know... It's also a big world with widespread critical need.
How do they say it? Oh, that's it: HELL YEAH !
1 more thing, in case you didn't know, from BioClonetics:
A direct relationship with the Serum Institute of India (founded in 1966 by Dr. Cyrus Poonawalla), "...the world's largest vaccine manufacturer by number of doses produced and sold globally (more than 1.5 billion doses)", preparing for sample production with $40M already budgeted for related clinical trials.
https://wefunder.com/updates/90585-houston-we-have-lift-off
http://www.seruminstittue.com/
It just keeps getting heavier & heavier...
ITV1, Enzolytics's flagship product, has proven to work extremely effectively in clinical trials abroad to treat HIV. "Enzolytics currently holds a 49% interest in Immunotech Laboratories BG-Europe (Bulgaria). Immunotech BG-Europe has a license for the development and commercialization of Enzolytics Patented ITV-1 Technology." ITV-1 is being marketed in Europe under trade name ImmuH. "The medicine has a positive effect on the treatment of different kinds of cancer, as it stimulates the immune answer and strengthens the immune system..."
https://www.immunotechlaboratoriesbg.com/
https://enzolytics.com/immunh-bg%2Feurope
Best of luck, YSUNG !
TUVM Misafixit. Owe it all to BREZLIN
DD = Due Diligence = Research. You'll see "DO YOUR OWN DD", "KNOW WHAT YOU OWN", "DONT DONT DONT MAKE DECISIONS BASED ON POSTS HERE - MAKE YOUR OWN". Here's an exceptional recap of ENZC DD to clue you in & get you started. It's thanks to BREZLIN, who you'll see here. Best wishes/good luck.
YO BREZ: THX A LOT! No plagiarism intended, just cleaned up the format a bit w a couple additions. You rule, guy.
10/14 - PR; Binding Letter of Intent
10/19 - PR; Company Update
10/21 - FILING; Quarterly Report, 2018
10/21 - FILING; Sup. Info Sept 2018
10/22 - PR; Charles Cotropia as CEO
10/26 - FILING; Sup. Info Dec. 2018
10/27 - FILING; Annual Rep. 2018
10/28 - FILING; DE SOS Reinstatement
Forward Looking;
10/28 - 11/2 - FILING; 2019s
10/28 - 11/2 - OTCM - Now current
CEO: Charles Cotropia, Esq.
Juris Doctorate, Cornell University
B.S., Aerospace Engineering, University of Texas
Mr. Cotropia is a patent attorney (over 40 years of exerience) with a squeaky clean, stellar record, and has overseen more than 200 patents held by the DECADES-old company (BioClonetics). He was instrumental in negotiating and finalizing the merger of Enzolytics and BioClonetics.
Co-CSO: Joseph Cotropia, M.D.
Doctor of Medicine, University of Texas Southwestern Medical School
Master of Science, Physiological Chemistry
Charles' brother is the medical doctor who developed CLONE3, the monoclodal antibody indicated to CURE the HIV virus, which causes AIDS. CLONE3 is the anitbody that Fauci attempted to pilfer from the Cotropias, but lost in court. Fauci is documented as having referred to the drug as “valuable”, and told Science magazine that he'd "put his money" on monoclonals providing a solution before a vaccine.
Co-CSO: Mr. Harry H. Zhabilov, Jr. - President & CEO (Former), ENZC
Master of Science, University of Chemical Technology and Metallurgy, Sofia, Bulgaria
Member, American Chemical Society and American Institute of Chemical Engineers
Former CSO at the following companies: GXP Biopharm, Inc., Immunotech Laboratories, Enzolytics
Former VP of R&D, Viral Genetics, Inc.
Mr. Zhabilov has long-term experience in protein isolation and purification in immunochemistry and biochemistry, along with experience manipulating therapeutic proteins used in HIV and cancer treatment. He is also experienced in the preparation of an application for a nutraceutical compound/supplement for the FDA. Mr. Zhabilov is the inventor of several U.S. patents which are related to the immunotherapy of HIV and cancer by acting as an immune enhancer based on the IPF platform. Furthermore, Mr. Zhabilov has also participated in several clinical trials utilizing therapeutic proteins.
COO: Gaurav Chandra, M.D.
Doctor of Medicine, Kasturba Medical School (Manipal, Karnataka, India)
** An on-staff consortium of leading physicians and scientists, in the USA and Europe, all with accomplished professional achievements, all referenced and listed on the company's web site(s), refining and enhancing escoteric, life-saving biotechnology with far-reaching human implications.
** DEVELOPED Monoclonal Antibodies!!! BioClonetics' patented proprietary technology, refined over decades, employ mAbs to prevent a virus from infecting a cell. This technology appears to be applicable throughout all species of fauna (i.e., across the entire "animal kingdom"). NOBODY HAS THIS.
http://bioclonetics.com/technology.html
http://www.bioclonetics.com/ip.html
** Five independent studies PROVING CLONE3 STOPS HIV, the virus that causes AIDS, in 98% of ALL KNOWN varieties world-wide. NOBODY HAS THIS.
http://www.bioclonetics.com/anti-hiv-technology.html
** ITV1, Enzolytics's flagship product, has proven to work extremely effectively in clinical trials abroad to treat HIV. "Enzolytics currently holds a 49% interest in Immunotech Laboratories BG-Europe (Bulgaria). Immunotech BG-Europe has a license for the development and commercialization of Enzolytics Patented ITV-1 Technology." ITV-1 is being marketed in Europe under trade name ImmuH. "The medicine has a positive effect on the treatment of different kinds of cancer, as it stimulates the immune answer and strengthens the immune system..."
https://www.immunotechlaboratoriesbg.com/
https://enzolytics.com/immunh-bg%2Feurope
** A direct relationship with the Serum Institute of India (founded in 1966 by Dr. Cyrus Poonawalla), "...the world's largest vaccine manufacturer by number of doses produced and sold globally (more than 1.5 billion doses)", preparing for sample production with $40M already budgeted for related clinical trials.
https://wefunder.com/updates/90585-houston-we-have-lift-off
http://www.seruminstittue.com/
** An Invitation for two of the company's physicians (one is Cotropia) to speak at Davos in 2021. Only the most reputable, respected companies and their officers are ever considered for participation. ONLY members of the upper echelon in their scientific field are invited to represent their profession. OK, OK: The Forum's been switched to Lucerne, Switzerland in May 2021, and reduced in scale.
https://www.ft.com/content/924cdb5c-4d5e-404b-8602-9708707d56b9
HELL YEAH YOU CAN, BUD...
You got it. Very best wishes for everyone!